Progress in Inflammation Research NMDA Antagonists as Potential Analgesic Drugs
Prijzen vanaf
88,28
Uitgelicht
|
88,28 |
Naar shop
|
| VERGELIJK ALLE AANBIEDERS (1) | ||
Beschrijving
Bol
There is now considerable preclinical evidence that glutamate acting via the NMDA receptor is involved in the transmission of nociceptive information and in the triggering mechanisms for hyperalgesia and allodynia. This evidence allows rational development of a new class of analgesic drugs that act as antagonists of the NMDA receptor, supported by emerging evidence with existing excitatory amino acid antagonists. L
Vergelijk aanbieders (1)
Shop
Prijs
Verzendkosten
Totale prijs
Beschrijving
(1)
There is now considerable preclinical evidence that glutamate acting via the NMDA receptor is involved in the transmission of nociceptive information and in the triggering mechanisms for hyperalgesia and allodynia. This evidence allows rational development of a new class of analgesic drugs that act as antagonists of the NMDA receptor, supported by emerging evidence with existing excitatory amino acid antagonists. L
Productspecificaties
| EAN |
|
|---|---|
| Maat |
|
Prijshistorie
Prijzen voor het laatst bijgewerkt op:
Gerelateerde resultaten
Uitgelichte Keuze
88,28
